A share price of AEON Biopharma Inc [AEON] is currently trading at $0.82, up 12.36%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The AEON shares have gain 42.36% over the last week, with a monthly amount glided 70.87%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
AEON Biopharma Inc [AMEX: AEON] stock has seen the most recent analyst activity on August 18, 2023, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $18.
AEON Biopharma Inc experienced fluctuations in its stock price throughout the past year between $0.38 and $269.28. AEON Biopharma Inc [AMEX: AEON] shares were valued at $0.82 at the most recent close of the market.
Analyzing the AEON fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at 13.37, Equity is -0.59 and Total Capital is -6.63. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.45.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7393 points at the first support level, and at 0.6587 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8653, and for the 2nd resistance point, it is at 0.9107.
Ratios To Look Out For
To put it in perspective, the Current Ratio for AEON Biopharma Inc [AMEX:AEON] is 1.43. Further, the Quick Ratio stands at 1.43, while the Cash Ratio is 0.0.
Transactions by insiders
Recent insider trading involved FISCHER JOST, Director, that happened on May 21 ’25 when 60000.0 shares were purchased. Director, FISCHER JOST completed a deal on May 20 ’25 to buy 60000.0 shares. Meanwhile, Director FISCHER JOST bought 50000.0 shares on May 19 ’25.
